Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Accounts Payables: 2022-2024

Historic Accounts Payables for NewGenIvf (NIVF) over the last 3 years, with FY2024 value amounting to $1.3 million.

  • NewGenIvf's Accounts Payables rose 43762.17% to $1.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.3 million, marking a year-over-year increase of 43762.17%. This contributed to the annual value of $1.3 million for FY2024, which is 43762.17% up from last year.
  • NewGenIvf's Accounts Payables amounted to $1.3 million in FY2024, which was up 43762.17% from $241613.0 recorded in FY2023.
  • NewGenIvf's 5-year Accounts Payables high stood at $1.3 million for FY2024, and its period low was $241613.0 during FY2023.
  • Its 3-year average for Accounts Payables is $610118.0, with a median of $289777.0 in 2022.
  • Per our database at Business Quant, NewGenIvf's Accounts Payables crashed by 1662.11% in 2023 and then soared by 43762.17% in 2024.
  • Annual analysis of 3 years shows NewGenIvf's Accounts Payables stood at $289777.0 in 2022, then dropped by 16.62% to $241613.0 in 2023, then surged by 437.62% to $1.3 million in 2024.
  • Its Accounts Payables stands at $1.3 million for FY2024, versus $241613.0 for FY2023 and $289777.0 for FY2022.